Sexual Function in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia: Results of a 6-Month, Randomized, Double-Blind, Placebo-Controlled Study of Tadalafil Coadministered with Finasteride

Glina, Sidney; Roehrborn, Claus; ESEN, AHMET; Plekhanov, Alexey; Sorsaburu, Sebastian; Henneges, Carsten; Buettner, Hartwig; Viktrup, Lars

doi:10.1111/jsm.12714

Sexual Function in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia: Results of a 6-Month, Randomized, Double-Blind, Placebo-Controlled Study of Tadalafil Coadministered with Finasteride

Glina S., Roehrborn C. G., ESEN A. A., Plekhanov A., Sorsaburu S., Henneges C., ...Daha Fazla

JOURNAL OF SEXUAL MEDICINE, cilt.12, sa.1, ss.129-138, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 12 Sayı: 1
Basım Tarihi: 2015
Doi Numarası: 10.1111/jsm.12714
Dergi Adı: JOURNAL OF SEXUAL MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.129-138
Anahtar Kelimeler: 5-Alpha Reductase Inhibitors, Benign Prostatic Hyperplasia, Ejaculatory Function, Erectile Dysfunction, Finasteride, Lower Urinary Tract Symptoms, Orgasmic Function, Phosphodiesterase Type 5 Inhibitors, Tadalafil
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

IntroductionTadalafil (TAD) 5mg coadministered with finasteride (FIN) 5mg significantly improves lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH) and prostatic enlargement. However, its effects on erectile/sexual function have yet to be fully described.